欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子化合物 > 小分子抑制剂 > GSK137647A

商品分类

浏览历史

S85041

GSK137647A

源叶(MedMol) 99%
  • 英文名:
  • GSK137647A
  • 别名:
  • CAS号:
  • 349085-82-1
  • 分子式:
  • C16H19NO3S
  • 分子量:
  • 305.392
  • 核磁/质谱:
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S85041-2mg 99% ¥208.00元 5 0 0 0 EA 加入购物车
源叶(MedMol) S85041-5mg 99% ¥352.00元 5 0 0 0 EA 加入购物车
源叶(MedMol) S85041-10mg 99% ¥480.00元 6 0 0 0 EA 加入购物车
源叶(MedMol) S85041-25mg 99% ¥960.00元 预计交期:2-3天 0 0 0 EA 加入购物车
源叶(MedMol) S85041-50mg 99% ¥1520.00元 预计交期:2-3天 0 0 0 EA 加入购物车
源叶(MedMol) S85041-100mg 99% ¥2560.00元 预计交期:2-3天 0 0 0 EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: GSK137647A (GSK 137647) is a potent, selective free fatty acid receptor 4 (FFA4) agonist with pEC50 values of 6.3, 6.2, and 6.1 for human, mouse and rat FFA4, and pEC50 values < 4.5 for all three species for FFA1, FFA2, and FFA3, respectively. GSK137647A has anti-inflammatory activity. GSK137647A induces insulin secretion and inhibits epithelial ion transport, GSK137647A is related to regulation of glucose homeostasis and anti-inflammatory response
  • 靶点: Free Fatty Acid Receptor
  • 体外研究: GSK137647A (GSK 137647) (50 µM) reduces the production of NO in macrophages without affecting cell viability[1].GSK137647A (GSK 137647) (30 µM; 12 hours) alleviates response to inflammatory stimuli in Caco-2 cells and induces secretion of IL-6[1]. GSK137647A (GSK 137647) (10 µM) reduces the ion flow and affects the colonic epithelial ion transport in healthy. GSK137647A (GSK 137647) (50 µM) increases glucose stimulated insulin secretion. Western Blot Analysis Cell Line: Caco-2 cells Concentration: 30 µM Incubation Time: 12 hours Result: Downregulated FFAR1, FFAR2, and FFAR4 as compared to control. Cell Viability Assay Cell Line: RAW264.7 macrophages Concentration: 10, 20 and 50 µM Incubation Time: 24 hours Result: Without affected cell viability.
  • 体内研究: GSK137647A (GSK 137647) (1 mg/kg; i.p.; twice daily, for 7 days; C57BL/6 mice) alleviates colitis in TNBS- and DSS-treated mice. GSK137647A (GSK 137647) (1 mg/kg; i.p.; twice daily, for 7 days; C57BL/6 mice) restores intestinal permeability in vivo. Animal Model: Male C57BL/6 mice Dosage: 1 mg/kg Administration: Intraperitoneal injection; twice daily, for 7 days Result: Had anti-inflammatory effect and reversed colonic injury induced by DSS. Animal Model: Male C57BL/6 mice Dosage: 1 mg/kg Administration: Intraperitoneal injection; twice daily, for 7 days Result: Decreased the amount of FITC and alleviated intestinal epithelial barrier permeability.
  • 参考文献:
    1. Salaga M, et, al. Activation of Free Fatty Acid Receptor 4 Affects Intestinal Inflammation and Improves Colon Permeability in Mice. Nutrients. 2021 Aug 6;13(8):2716. 2. Sparks SM, et, al. Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120). Bioorg Med Chem Lett. 2014 Jul 15;24(14):3100-3.
  • 溶解性: Soluble  in  DMSO、H2O
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 3.274 ml 16.372 ml 32.745 ml
    5 mM 0.655 ml 3.274 ml 6.549 ml
    10 mM 0.327 ml 1.637 ml 3.274 ml
    50 mM 0.065 ml 0.327 ml 0.655 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。